Ackermans & Van Haaren NV (GB:0GYM) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Ackermans & van Haaren NV reports a strong third quarter in 2024, maintaining momentum with core participations like DEME and Delen Private Bank, and projects a net profit exceeding 400 million euros for the year. The company bolstered its portfolio with strategic investments in V.Group and Confo Therapeutics, while also increasing stakes in Nextensa and SIPEF. AvH’s financial position remains solid with a net cash position of 294.8 million euros as of September 2024.
For further insights into GB:0GYM stock, check out TipRanks’ Stock Analysis page.
